Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data

Canadian Journal of Cardiology

Volumn 13, Issue 10, 1997, Pages 957-965

  Lonn, Eva M ^a,b   Yusuf, Salim ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

Antioxidant vitamins; Cardiovascular disease; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; EPIDEMIOLOGIC STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; VITAMIN E; VITAMINS;

EID: 0030780093     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Steinberg D, Parthasarathy S, Carew T, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
2. Steinberg D, Witztum J. Lipoproteins and atherogenesis. JAMA 1990;264:3047-52.
3. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992;85:2338-43
4. Fruebis J, Steinberg D, Dresel HA, Carew TE. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. J Clin Invest 1994;94:392-8.
5. Jialal I, Fuller CJ. Oxidized LDL and antioxidants. Clin Cardiol 1993;16(Suppl I):16-9.
6. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447-51.
7. Hertog MG, Feskens EJ, Holman PC, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zurphen Elderly Study. Lancet 1993;342:1007-11.
8. Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study JAMA 1995;274:131-6.
9. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9.
10. Kushi LH, Fulsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-62.
11. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
12. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-90.
13. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462-8.
14. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226-31.
15. Gaziano JM, Manson JE, Branch LG, et al. Dietary beta-carotene and decreased cardiovascular mortality in an elderly cohort. J Am Coll Cardiol 1992;19(Suppl A):377A. (Abst)
16. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993;57(5 Suppl):787S-97S.
17. Morris DI, Kritchevsky SB, Davis CE. Serum carotenoids and coronarv heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA 1994;272:1439-41.
18. Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta-carotene and the effect of oral supplementation. JAMA 1996;275:699-703.
19. Street DA, Comstock GW, Salkeld RM, Shuep W, King M. A population-based case-control study of the association of serum antioxidants and myocardial infarction. Am J Epidemiol 1991;134:719-20.
20. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.
21. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995;310:1563-6.
22. Enstrom JE, Kanim LE, Breslow L. The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California. Am J Public Health 1986;76:1124-30.
23. Lapidus L, Andersson H, Bengtsson C, Bosaeus I. Dietary habits in relation to incidence of cardiovascular disease and death in women: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Clin Nutr 1986;44:444-5.
24. Livingston PD, Jones C. Treatment of intermittent claudication with vitamin E. Lancet 1958;ii:602-4.
25. Williams HTG, Fenna D, MacBeth RA. Alpha tocopherol in the treatment of intermittent claudication. Surg Gynecol Obstet 1971;April:662-6.
26. Haeger K. Long time treatment of intermittent claudication with vitamin E. Am J Clin Nutr 1974;27:1179-81.
27. Gillilan RE, Mandell B, Warbasse JR. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am Heart J 1977;93:444-9.
28. DeMaio SJ, King SB III, Lembo KJ, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992;11:68-73.
29. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
30. Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris: a randomized, double-blind, controlled trial. JAMA 1996;275:693-8.
31. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715-20.
32. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
33. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
34. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
35. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of longterm supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 1996;334:1145-9.
36. Greenberg ER, Baron JA, Stukel TA, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med 1990;323:789-95.
37. Wilson TS, Datta SB, Murrell JS, Andrews CT. Relation of vitamin C levels to mortality in a geriatric hospital: a study of the effect of vitamm C administration. Age Aging 1973;2:163-17.